To ask Her Majesty's Government whether they intend to prioritise imports of medicine in their post-Brexit trading arrangements, in the event of a no-deal scenario.
DHSC are working closely with life sciences industry and the NHS to make detailed plans to ensure continued access to medicines and devices in all scenarios.
We are working with industry to reroute supplies that make use of freight capacity acquired by Government. Medicines and medical products will be prioritised within this additional capacity to ensure that the flow of all these products will continue unimpeded after 29 March 2019. In addition, we are working with pharmaceutical companies to ensure that there is a minimum of six weeks additional supply of medicines in the UK, over and above existing business-as-usual buffer stocks.